Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

1237.25.10504 Boehringer Ingelheim Investigational Site, Wheat Ridge

1237.25.10507 Boehringer Ingelheim Investigational Site, Clearwater

1237.25.10517 Boehringer Ingelheim Investigational Site, Panama City

1237.25.10505 Boehringer Ingelheim Investigational Site, Coeur d'Alene

1237.25.10516 Boehringer Ingelheim Investigational Site, Ann Arbor

1237.25.10509 Boehringer Ingelheim Investigational Site, Livonia

1237.25.10519 Boehringer Ingelheim Investigational Site, Charlotte

1237.25.10503 Boehringer Ingelheim Investigational Site, Cincinnati

1237.25.10518 Boehringer Ingelheim Investigational Site, Columbia

1237.25.10502 Boehringer Ingelheim Investigational Site, Columbus

1237.25.10511 Boehringer Ingelheim Investigational Site, Dublin

1237.25.10514 Boehringer Ingelheim Investigational Site, Philadelphia

1237.25.10513 Boehringer Ingelheim Investigational Site, Charleston

1237.25.10515 Boehringer Ingelheim Investigational Site, Easley

1237.25.10506 Boehringer Ingelheim Investigational Site, Greenville

1237.25.10501 Boehringer Ingelheim Investigational Site, Rock Hill

1237.25.10508 Boehringer Ingelheim Investigational Site, Spartanburg

1237.25.10520 Boehringer Ingelheim Investigational Site, Killeen

1237.25.10510 Boehringer Ingelheim Investigational Site, Richmond

1237.25.10521 Boehringer Ingelheim Investigational Site, Spokane

1237.25.32001 Boehringer Ingelheim Investigational Site, Brussels

1237.25.32004 Boehringer Ingelheim Investigational Site, Brussels

1237.25.32005 Boehringer Ingelheim Investigational Site, Eupen

1237.25.32003 Boehringer Ingelheim Investigational Site, Lebbeke

1237.25.32002 Boehringer Ingelheim Investigational Site, Turnhout

1237.25.11508 Boehringer Ingelheim Investigational Site, Calgary

1237.25.11504 Boehringer Ingelheim Investigational Site, Edmonton

1237.25.11501 Boehringer Ingelheim Investigational Site, Vancouver

1237.25.11505 Boehringer Ingelheim Investigational Site, Burlington

1237.25.11507 Boehringer Ingelheim Investigational Site, Grimsby

1237.25.11510 Boehringer Ingelheim Investigational Site, Ottawa

1237.25.11502 Boehringer Ingelheim Investigational Site, Québec

1237.25.11506 Boehringer Ingelheim Investigational Site, Québec

1237.25.11509 Boehringer Ingelheim Investigational Site, Sherbrooke

1237.25.42003 Boehringer Ingelheim Investigational Site, Jindřichův Hradec

1237.25.42005 Boehringer Ingelheim Investigational Site, Karlovy Vary-Drahovice

1237.25.42002 Boehringer Ingelheim Investigational Site, Neratovice

1237.25.42001 Boehringer Ingelheim Investigational Site, Prague

1237.25.42004 Boehringer Ingelheim Investigational Site, Rokycany

1237.25.45003 Boehringer Ingelheim Investigational Site, Aalborg

1237.25.45002 Boehringer Ingelheim Investigational Site, Hellerup

1237.25.45001 Boehringer Ingelheim Investigational Site, Odense

1237.25.45004 Boehringer Ingelheim Investigational Site, Silkeborg

1237.25.35802 Boehringer Ingelheim Investigational Site, Pori

1237.25.35801 Boehringer Ingelheim Investigational Site, Turku

1237.25.35803 Boehringer Ingelheim Investigational Site, Turku

1237.25.49504 Boehringer Ingelheim Investigational Site, Berlin

1237.25.49508 Boehringer Ingelheim Investigational Site, Berlin

1237.25.49510 Boehringer Ingelheim Investigational Site, Berlin

1237.25.49501 Boehringer Ingelheim Investigational Site, Großhansdorf

1237.25.49505 Boehringer Ingelheim Investigational Site, Halle

1237.25.49506 Boehringer Ingelheim Investigational Site, Hamburg

1237.25.49515 Boehringer Ingelheim Investigational Site, Hamburg

1237.25.49509 Boehringer Ingelheim Investigational Site, Hanover

1237.25.49514 Boehringer Ingelheim Investigational Site, Koblenz

1237.25.49507 Boehringer Ingelheim Investigational Site, Mainz

1237.25.49502 Boehringer Ingelheim Investigational Site, Neu-Isenburg

1237.25.49516 Boehringer Ingelheim Investigational Site, Oschersleben

1237.25.49511 Boehringer Ingelheim Investigational Site, Rodgau

1237.25.49503 Boehringer Ingelheim Investigational Site, Rosenheim

1237.25.49513 Boehringer Ingelheim Investigational Site, Teuchern

1237.25.27506 Boehringer Ingelheim Investigational Site, Bloemfontein

1237.25.27501 Boehringer Ingelheim Investigational Site, Cape Town

1237.25.27505 Boehringer Ingelheim Investigational Site, eMkhomazi

1237.25.27504 Boehringer Ingelheim Investigational Site, Morningside, Sandton

1237.25.27502 Boehringer Ingelheim Investigational Site, Parow

1237.25.27503 Boehringer Ingelheim Investigational Site, Pretoria

1237.25.34003 Boehringer Ingelheim Investigational Site, Alicante

1237.25.34007 Boehringer Ingelheim Investigational Site, Barcelona

1237.25.34001 Boehringer Ingelheim Investigational Site, Mérida

1237.25.34002 Boehringer Ingelheim Investigational Site, Pozuelo de Alarcón

1237.25.34004 Boehringer Ingelheim Investigational Site, Vic

1237.25.44002 Boehringer Ingelheim Investigational Site, Bradford

1237.25.44001 Boehringer Ingelheim Investigational Site, Chertsey

1237.25.44004 Boehringer Ingelheim Investigational Site, Chester

1237.25.44005 Boehringer Ingelheim Investigational Site, Chippenham

1237.25.44003 Boehringer Ingelheim Investigational Site, Wolverhampton